Outcome measures for balneotherapy NATIONAL INSTITUTE OF RHEUMATOLOGY AND PHYSIOTHERAPY Budapest, Hungary Dr. LÁSZLÓ HODINKA Recommendations.

Slides:



Advertisements
Similar presentations
Measuring outcomes Emma Frew October Measuring outcomes Learning objectives By the end of the session students should be able to – Explain how different.
Advertisements

Emma Frew Introduction to health economics, MSc HEHP, October 2012 Outcomes: part II.
Defining Remission in Rheumatoid Arthritis. Part 1: Why is a new remission definition in rheumatoid arthritis needed?
Responding to the Patient’s Voice: the importance of Patient Reported Outcomes Dr. Kirstie Haywood Senior Research Fellow RCN Research Institute, School.
Spa Therapy and Balneotherapy for Fibromyalgia in Turkey A Dönmez.
Lifestyle Modifications in Lupus: What’s the Evidence? Margy Holyst, M.D.
1 Fibromyalgia: A Chronic Widespread Neurologic Pain Condition Disease Overview, Diagnosis, and Management PBP00542 © 2009 Pfizer Inc. All rights reserved.
Patients with Rheumatoid Arthritis in Comparison to Other Connective Tissue Diseases Are Mostly Influenced by Concomitant Fibromyalgia Tomš J, Daňková.
+ Bridging the rural-urban divide for patients with rheumatoid arthritis Brenna Bath School of Physical Therapy University of Saskatchewan.
Evidence in Balneology – the current situation Christoph Gutenbrunner Christoph Gutenbrunner, MD, PhD, Professor Department for Physical Medicine and Rehabilitation.
The organisation of research on thermalism in Europe – The situation in eastern Europe and Turkey M. Zeki KARAGÜLLE Department of Medical Ecology and Hydroclimatology.
THE EFFICACY OF BALNEOTHERAPY IN KNEE OSTEOARTHRITIS Serap ALPER MD. Dokuz Eylül University Physical Medicine and Rehabilitation Department İZMİR.
What is the definition of remission in RA? American Rheumatism Association (ARA)¹ Five or more of the following criteria must be fulfilled for at least.
Ufuk Şen M Zeki Karagülle
Fibromyalgia: Creating a Claim James Witter MD, PhD Arthritis Advisory Committee June 23, 2003.
Measuring Signs and Symptoms in Rheumatoid Arthritis David R. Karp, MD, PhD Chief, Rheumatic Diseases UT Southwestern Medical Center David R. Karp, MD,
Diana M. Taibi, PhD, RN Biobehavioral Nursing & Health Systems University of Washington WUN, 2010 Building a Program of Research on Yoga for Osteoarthritis.
Outcomes in Randomized Controlled Trials in Pain: A Proposed Responder Analysis Vibeke Strand, MD Biopharmaceutical Consultant Clinical Professor, Division.
Steffany Moonaz, PhD, RYT-500.  The emerging evidence since 2011…
The Impact of IMMPACT Bob A. Rappaport, M.D. Director Division of Anesthesia, Analgesia and Rheumatology Products Center for Drug Evaluation and Research.
Exercise in Ankylosing Spondylitis Prof. Pál Géher MD.
A randomized, double-blind study on MD-knee versus HA in patients affected by knee OA: preliminary data from the JOINT study Umberto Massafra Dep of Rheumatology,
Effects of hydrotherapy in Knee Osteoarthritis
BALNEOTHERAPY IN THE TREATMENT OF FIBROMYALGIA SYNDROME Doç Dr Lale Altan, Uludağ University Medical Faculty Atatürk Rehabilitation Center Kükürtlü Spa.
PRINCIPLES OF GOOD CLINICAL PRACTICE IN THERMAL REHABILITATION PRINCIPLES OF GOOD CLINICAL PRACTICE IN THERMAL REHABILITATION  De Fabritiis M. _ Masiero.
Epidemiology and prognosis of osteoarthritis 111 Joost Dekker PhD Department of Rehabilitation Medicine & Department of Psychiatry VU University Medical.
Yusuf Yazıcı, MD NYU Hospital for Joint Diseases
Spa Therapy and Balneotherapy in Fibromyalgia Arif Dönmez.
Evidenced-Based Interventions for Preventing Further Limitations in Occupational Performance in Individuals with Fibromyalgia Vision in Action Conference.
Jaw Pain: Characteristics and Prevalence in Fibromyalgia and other Rheumatic Disorders Robert S. Katz 1, Frederick Wolfe 2. 1 Rush University Med Center,
Rehabilitation Teaching and Research Unit, Wellington School of Medicine and Health Sciences Outcome measures in psoriatic arthritis Preliminary identification.
Why use the EQ-5D? What are the alternatives?. What are the alternatives for Direct valuation? Other VAS Time Trade-Off Standard Gamble Willingness to.
PsA: Review of Available Assessment Instruments and Lessons from Trial Results Part II Christian Antoni Friedrich Alexander University Erlangen-Nürnberg.
Effect of balneotherapy on plasma cytokine levels
Spa therapy for lumbar spine osteoarthritis M. Zeki Karagülle Istanbul University Istanbul Medical Faculty Department of Medical Ecology and Hydroclimatology.
Validation of the OMERACT-OARSI Responder Index: Responders Have Better Overall Health Status than Non-responders Marc C. Hochberg, Barker Bausell, Kevin.
1 EEG Biofeedback in Fibromyalgia Syndrome Sadi Kayıran, M.D., Erbil Dursun, M.D., Nigar Dursun, M.D. Kocaeli University Physical Medicine & Rehabilitation.
Balneotherapy for Chronic Low Back Pain Prof. Dr. M. Zeki Karagülle.
Balneotherapy in Rheumatologic Conditions Dr. Deniz EVCİK Kocatepe University,Dep. of PRM,Afyon- TURKEY.
Workshop The science and methodologies behind HTA, diversity and commonality across the EU Achieving more patient centred HTA in different countries.
Introduction: Medical Psychology and Border Areas
OMERACT 8 PsA Module Co-Chairs Dafna Gladman and Philip Mease Steering Committee Alice Gottlieb, Philip Helliwell, Arthur Kavanaugh, Gerry Krueger, Peter.
Health economy – applications for balneotherapy Dr. László Hodinka National Insitute of Rheumatology and Physiotherapy.
Yusuf Yazıcı, MD NYU Hospital for Joint Diseases, New York
EFFICACY OF SPA THERAPY IN RHEUMATOID ARTHRITIS-A RANDOMISED CONTROLLED CLINICAL STUDY Mine Karagülle Department of Medical Ecology and Hydroclimatology.
Innovation in balneotherapy – challenge of new target diseases and conditions National Institute of Rheumatology and Physiotherapy, Budapest, Hungary National.
Saving time and improving care with a multidimensional health assessment questionnaire: 10 practical considerations T Pincus, Y Yazici, M Bergman J Rheumatol.
OMERACT 8 PsA Module Co-Chairs Dafna Gladman and Philip Mease Steering Committee Alice Gottlieb, Oliver FitzGerald, Philip Helliwell, Arthur Kavanaugh,
1 Assessing Disease Activity Janice Booth Rheumatology Nurse Practitioner January 2012.
OMERACT Workshop Outcome Measures in Psoriatic Arthritis
BALNEOTHERAPY AND PAIN Dr Arif Dönmez Balçova-İzmir.
SARAH: Strengthening and Stretching for Rheumatoid Arthritis Affecting the Hand: A randomised controlled trial Adams J, Williams MA, Heine PJ, McConkey.
Correlations among Pain Severity, Functional Impairment and Clinical Symptoms in Fibromyalgia Rebecca L. Ross PhD, RN, PMHNP-BC, Assistant Professor.
Outcome Measures in PsA Philip Mease MD Seattle, WA.
Efectivness of Spa Therapy in Severe Knee Osteoarthritis; Randomize Controlled Trial Mine Karagülle,MD Istanbul, Turkey.
Perspectives on Clinical Outcomes of Studies of Products for Use in Cartilage Repair Marc C. Hochberg, MD, MPH Professor of Medicine Head, Division of.
OMERACT 8 PsA Module Proposal Submitted by: Dafna Gladman and Philip Mease.
GRAPPA Committee Reports and Outcome measures Dafna D. Gladman, MD, FRCPC Professor of Medicine, University of Toronto Director, PsA Program, University.
Long-Term Outcomes after Acute Stroke Treatment Larry B. Goldstein, M.D. Professor of Medicine (Neurology) Center for Cerebrovascular Disease Center for.
Update on Frailty Assessment in Older Patients with Aortic Stenosis Dr Amy Jones ST5/Clinical Research Fellow Geriatric Medicine.
Fibromyalgia Impact Questionnaire McGill Pain Questionnaire
Quality of Life Assessment
Patients were considered not in MDA (MDA−) with a score of 0, 1, 2, 3 or 4 points and in MDA (MDA+) with a score of 5, 6 or 7 points.
Efficacy end points: the percentage of patients achieving an improvement in American College of Rheumatology (ACR) of (A) 20% (ACR20), (B) 50% (ACR50)
Improvement in PROs, TJC, SJC and PGA at month 6 in patients achieving (A) ACR50, (B) CDAI LDA and (C) HAQ-DI
Additional efficacy outcomes for the 12-week study of Japanese patients with rheumatoid arthritis treated with baricitinib or placebo. Additional efficacy.
Clinical response in patients with early and established RA at month 24. *p
Improvement in PROs, TJC, SJC and PGA at month 6 in patients achieving (A) ACR70, (B) CDAI REM and (C) SDAI REM. For tofacitinib 5 and 10 mg BID treatment.
Measuring outcomes Emma Frew October 2012.
Explanatory power of the LPA solution for clinical and functional outcomes compared with the conventional threshold-based discordance definition. Explanatory.
Presentation transcript:

Outcome measures for balneotherapy NATIONAL INSTITUTE OF RHEUMATOLOGY AND PHYSIOTHERAPY Budapest, Hungary Dr. LÁSZLÓ HODINKA Recommendations

Fundamental questions of balneotherapy (I.) Definition of curative water: –hygienic / administrative: suitable for therapeutic use –evidence based: beneficial / curative effects What are the physiological effects of immersion into thermal / mineral water? Are these different from the effects of normal water? Does immersion into thermal / mineral water influence any biological / pathological response in disease states?

Fundamental questions of balneotherapy (II.) Is the immersion effective itself, or when combined with any activity or climatical factor? How can we measure / prove the changes? Are these changes beneficial / curative ? What are the main domains of the benefit?

Measures applied in balneotherapy trials (I) RA Pain VAS, (pat) activity vAS (pat), activity VAS (doctor), morning stiffness, Ritchie, painful and swollen joints, walking distance, PIP circumference, activities of daily living ADL / HAQ, AIMS, Keitel index (Yurtkuran, Sukenik, Franke, Elkayam) A. psor. morning stiffness, grip strenght, activity VAS (pat), active joints, Ritchie, vertebral pain + ROM, PASI, tender point pain (Dolorimeter) (Sukenik, Elkayam) SPA morning pain and stiffness, spine ROM, activity (pat + doctor - 3 / +3 grade) (Tubengen, Tischler) RA Pain VAS, (pat) activity vAS (pat), activity VAS (doctor), morning stiffness, Ritchie, painful and swollen joints, walking distance, PIP circumference, activities of daily living ADL / HAQ, AIMS, Keitel index (Yurtkuran, Sukenik, Franke, Elkayam) A. psor. morning stiffness, grip strenght, activity VAS (pat), active joints, Ritchie, vertebral pain + ROM, PASI, tender point pain (Dolorimeter) (Sukenik, Elkayam) SPA morning pain and stiffness, spine ROM, activity (pat + doctor - 3 / +3 grade) (Tubengen, Tischler)

Measures applied in balneotherapy trials (II) OA Pain VAS (pat), severity (pat + doctor - 3 / +3 grade), ROM, Lequesne index, step- walk time, funcional state, AIMS, walking distance, QoL (Duke Health Profile (Wigler, Elkayam, Kovács, Sukenik, Nguyen, Forester, Guillemin Back pain Pain VAS (pat), Laségue, spine ROM, drug need, function (Roland-Morris), QoL (Duket Health Profile) (Konrád, Constant, Guillemin) Fibromyalgia Pain, fatigue, anxiety, Sleep disturbance (VAS, pat) tender points, dolorimetry (Fischer), HAQ (FDI), SF-36, AIMS, FIQ, Beck EI (Yurtkuran, Ervcik, Neuman, Buskila) (reviewed by: I. Tefner, Natl. Inst. Rheum. Phys. Med. Budapest) OA Pain VAS (pat), severity (pat + doctor - 3 / +3 grade), ROM, Lequesne index, step- walk time, funcional state, AIMS, walking distance, QoL (Duke Health Profile (Wigler, Elkayam, Kovács, Sukenik, Nguyen, Forester, Guillemin Back pain Pain VAS (pat), Laségue, spine ROM, drug need, function (Roland-Morris), QoL (Duket Health Profile) (Konrád, Constant, Guillemin) Fibromyalgia Pain, fatigue, anxiety, Sleep disturbance (VAS, pat) tender points, dolorimetry (Fischer), HAQ (FDI), SF-36, AIMS, FIQ, Beck EI (Yurtkuran, Ervcik, Neuman, Buskila) (reviewed by: I. Tefner, Natl. Inst. Rheum. Phys. Med. Budapest)

Evaluation of randomized clinical trials in balneotherapy Strengths: Evidence based protocol settings Efforts to apply relevant indicators Weaknesses: Use of arbitrary, „home made” or less known parameters Focus on disease activity and pain Rarely apply functional tests Almost complete lack of QoL and psychosocial measures No effort for health economy argumentation

OMERACT requirements on outcome measures Discriminative measuresEvaluative measures chareacterize groupsmeasure response sensitive for groupsensitive for changes means, medians, etcindicates differences over time Measures should be valid, differentiating, easily applicable Discriminative measuresEvaluative measures chareacterize groupsmeasure response sensitive for groupsensitive for changes means, medians, etcindicates differences over time Measures should be valid, differentiating, easily applicable

Recommended disease specific outcome measures for balneotherapy RAEULAR core set / DAS 28: (pain VAS-pat, activity VAS-pat, ESR, swollen and tender points) Simplified disease activity index (SDAI-swollen) as above + activity VAS-doctor, CRP instead of ESR RADAI (Stucki) RA QoL, HAQ (less ClinHAQ, MHAQ, MDHAQ) ACR or EULAR improvement 9ACR 20, 50, 70, DAS 28 limits A. psorPASI, PsorHAQ, ApsorQoL SpABASDAI, BASFI, BASMI, ASAS improvement criteria OAWomac scales, Lequesne index Low back pain:ROM, Oswestry index, Roland and Morris index Fibromyalgia:tender points + Fischer dolorimetry + pain threshold FIQ, fatigue + psychosocial incl, cognitive tests RAEULAR core set / DAS 28: (pain VAS-pat, activity VAS-pat, ESR, swollen and tender points) Simplified disease activity index (SDAI-swollen) as above + activity VAS-doctor, CRP instead of ESR RADAI (Stucki) RA QoL, HAQ (less ClinHAQ, MHAQ, MDHAQ) ACR or EULAR improvement 9ACR 20, 50, 70, DAS 28 limits A. psorPASI, PsorHAQ, ApsorQoL SpABASDAI, BASFI, BASMI, ASAS improvement criteria OAWomac scales, Lequesne index Low back pain:ROM, Oswestry index, Roland and Morris index Fibromyalgia:tender points + Fischer dolorimetry + pain threshold FIQ, fatigue + psychosocial incl, cognitive tests

Psychosocial measures are highly recommended in musculoskeletal trials Depression, anxiety, health cognition, fatigue, coping skills, positive mood, helplessness, stress, somatization, sleep, social support Reviewed by Brooks et al, Wolfe [OMERACT workshop report J. Rheumatology 24 (1997)] Depression, anxiety, health cognition, fatigue, coping skills, positive mood, helplessness, stress, somatization, sleep, social support Reviewed by Brooks et al, Wolfe [OMERACT workshop report J. Rheumatology 24 (1997)]

Generic health state and QoL measures and health economy SF-36, EuroQoL5D, less Nottingham Health Pofile Psychosocial outcomes Utility calculations:direct and indirect costs of disease specific QALYs or QALDays based on EuroQoL Health States SF-36, EuroQoL5D, less Nottingham Health Pofile Psychosocial outcomes Utility calculations:direct and indirect costs of disease specific QALYs or QALDays based on EuroQoL Health States

Conclusion Effectiveness of balneotherapy should be proven by Evidence Based Medicine approved indicators and instruments Focus on rehabilitation, functional and QoL improvement Based on QoL improvements, prove efficacy in terms of health economy Effectiveness of balneotherapy should be proven by Evidence Based Medicine approved indicators and instruments Focus on rehabilitation, functional and QoL improvement Based on QoL improvements, prove efficacy in terms of health economy